Skip to main content

What the FDA labels say about taking them together

Cyclosporine and levamlodipine

Levamlodipine's FDA label of December 11, 2024 names cyclosporine in its drug interactions section; the cyclosporine labels PlainMeds reads (4) do not name levamlodipine. The levamlodipine label: “Immunosuppressants Amlodipine may increase the systemic exposure of cyclosporine or tacrolimus when co-administered.”

Check it at the source: the cyclosporine FDA label on DailyMed (effective August 10, 2026, Novartis Pharmaceuticals Corporation); the levamlodipine FDA label on DailyMed (effective December 11, 2024, CSPC Ouyi Pharmaceutical Co. Ltd).

What does the cyclosporine label say about levamlodipine?

Cyclosporine's label (effective August 10, 2026) and its 3 other brand-application labels do not name levamlodipine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Neoral), Novartis Pharmaceuticals Corporation, effective August 10, 2026 (SPL set 94461af3-11f1-4670-95d4-2965b9538ae3), via openFDA; the full label on DailyMed

What does the levamlodipine label say about cyclosporine?

Levamlodipine label, drug interactions

Immunosuppressants Amlodipine may increase the systemic exposure of cyclosporine or tacrolimus when co-administered.

Source: FDA drug label (Conjupri), CSPC Ouyi Pharmaceutical Co. Ltd, effective December 11, 2024 (SPL set c3cca66e-348a-43e8-8f96-e995104dae3d), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

14Cyclosporine generic labelers
0Levamlodipine generic labelers
CyclosporineLevamlodipine
Labeled forOrgan transplant rejection, Rheumatoid arthritisHigh blood pressure
Boxed warningYesNo
Pharmacy cost (NADAC)$1.04 per unit 0.05% eye emulsionn/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?